180 related articles for article (PubMed ID: 24411949)
1. Insulin-like growth factor II messenger RNA-binding protein 3 expression in gastrointestinal mesenchymal tumors.
Yamamoto H; Arakaki K; Morimatsu K; Zaitsu Y; Fujita A; Kohashi K; Hirahashi M; Motoshita J; Oshiro Y; Oda Y
Hum Pathol; 2014 Mar; 45(3):481-7. PubMed ID: 24411949
[TBL] [Abstract][Full Text] [Related]
2. Oncofetal protein IMP3, a new diagnostic biomarker to distinguish malignant mesothelioma from reactive mesothelial proliferation.
Shi M; Fraire AE; Chu P; Cornejo K; Woda BA; Dresser K; Rock KL; Jiang Z
Am J Surg Pathol; 2011 Jun; 35(6):878-82. PubMed ID: 21566519
[TBL] [Abstract][Full Text] [Related]
3. Oncofetal protein IMP3: a useful diagnostic biomarker for leiomyosarcoma.
Cornejo K; Shi M; Jiang Z
Hum Pathol; 2012 Oct; 43(10):1567-72. PubMed ID: 22497850
[TBL] [Abstract][Full Text] [Related]
4. [Gastrointestinal stromal tumors: definition, histological, immunohistochemical, and molecular features, and diagnostic strategy].
Coindre JM; Emile JF; Monges G; Ranchère-Vince D; Scoazec JY
Ann Pathol; 2005 Oct; 25(5):358-85; quiz 357. PubMed ID: 16498290
[TBL] [Abstract][Full Text] [Related]
5. Primary leiomyosarcomas of the gastrointestinal tract in the post-gastrointestinal stromal tumor era.
Aggarwal G; Sharma S; Zheng M; Reid MD; Crosby JH; Chamberlain SM; Nayak-Kapoor A; Lee JR
Ann Diagn Pathol; 2012 Dec; 16(6):532-40. PubMed ID: 22917807
[TBL] [Abstract][Full Text] [Related]
6. Expression of Ets-1 proto-oncoprotein in gastrointestinal stromal tumors, leiomyomas and schwannomas.
Nakayama T; Yoshizaki A; Naito S; Wen CY; Alipov G; Yakata Y; Sekine I
World J Gastroenterol; 2006 Mar; 12(11):1743-6. PubMed ID: 16586544
[TBL] [Abstract][Full Text] [Related]
7. IMP3 Immunohistochemical Expression Remains Consistent Among All Grades of Gastrointestinal Neuroendocrine Tumors.
Agostini-Vulaj D; Whitney-Miller CL; Gonzalez RS; McMahon LA; Findeis-Hosey JJ
Appl Immunohistochem Mol Morphol; 2018 Apr; 26(4):288-293. PubMed ID: 27438513
[TBL] [Abstract][Full Text] [Related]
8. Gastrointestinal stromal tumors--definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis.
Miettinen M; Lasota J
Virchows Arch; 2001 Jan; 438(1):1-12. PubMed ID: 11213830
[TBL] [Abstract][Full Text] [Related]
9. Gastrointestinal stromal tumors: recent advances in understanding of their biology.
Miettinen M; Sarlomo-Rikala M; Lasota J
Hum Pathol; 1999 Oct; 30(10):1213-20. PubMed ID: 10534170
[TBL] [Abstract][Full Text] [Related]
10. Distinguishing gastrointestinal stromal tumors from their mimics: an update.
Abraham SC
Adv Anat Pathol; 2007 May; 14(3):178-88. PubMed ID: 17452814
[TBL] [Abstract][Full Text] [Related]
11. Malignant gastrointestinal neuroectodermal tumor: Cytologic, histologic, immunohistochemical, and molecular pitfalls.
Sivasubramaniam P; Tiegs-Heiden CA; Sturgis CD; Hagen CE; Hartley CP; Thangaiah JJ
Ann Diagn Pathol; 2021 Dec; 55():151813. PubMed ID: 34509898
[TBL] [Abstract][Full Text] [Related]
12. Practical utility of insulin-like growth factor II mRNA-binding protein 3, glucose transporter 1, and epithelial membrane antigen for distinguishing malignant mesotheliomas from benign mesothelial proliferations.
Chang S; Oh MH; Ji SY; Han J; Kim TJ; Eom M; Kwon KY; Ha SY; Choi YD; Lee CH; Lee Y; Jung SH
Pathol Int; 2014 Dec; 64(12):607-12. PubMed ID: 25376377
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor II-messenger RNA-binding protein-3 and lung cancer.
Findeis-Hosey JJ; Xu H
Biotech Histochem; 2012 Jan; 87(1):24-9. PubMed ID: 21838610
[TBL] [Abstract][Full Text] [Related]
14. The oncofetal protein IMP3: a novel biomarker for endometrial serous carcinoma.
Zheng W; Yi X; Fadare O; Liang SX; Martel M; Schwartz PE; Jiang Z
Am J Surg Pathol; 2008 Feb; 32(2):304-15. PubMed ID: 18223334
[TBL] [Abstract][Full Text] [Related]
15. IMP3/L523S, a novel immunocytochemical marker that distinguishes benign and malignant cells: the expression profiles of IMP3/L523S in effusion cytology.
Ikeda K; Tate G; Suzuki T; Kitamura T; Mitsuya T
Hum Pathol; 2010 May; 41(5):745-50. PubMed ID: 20060157
[TBL] [Abstract][Full Text] [Related]
16. IMP3 and GLUT-1 immunohistochemistry for distinguishing benign from malignant mesothelial proliferations.
Lee AF; Gown AM; Churg A
Am J Surg Pathol; 2013 Mar; 37(3):421-6. PubMed ID: 23108021
[TBL] [Abstract][Full Text] [Related]
17. DOG1 is a sensitive and specific immunohistochemical marker for diagnosis of canine gastrointestinal stromal tumors.
Dailey DD; Ehrhart EJ; Duval DL; Bass T; Powers BE
J Vet Diagn Invest; 2015 May; 27(3):268-77. PubMed ID: 25862711
[TBL] [Abstract][Full Text] [Related]
18. PDGFR expression in differential diagnosis between KIT-negative gastrointestinal stromal tumours and other primary soft-tissue tumours of the gastrointestinal tract.
Rossi G; Valli R; Bertolini F; Marchioni A; Cavazza A; Mucciarini C; Migaldi M; Federico M; Trentini GP; Sgambato A
Histopathology; 2005 May; 46(5):522-31. PubMed ID: 15842634
[TBL] [Abstract][Full Text] [Related]
19. [Differential diagnosis and treatment of esophageal stromal tumors and smooth muscle tumors].
Zhang X; Rong TH; Wu QL; Fu JH; Long H; Zhang LJ; Ma GW; Su XD; Li XD; Wang DF; Hu Y; Yang H
Ai Zheng; 2006 Jul; 25(7):901-5. PubMed ID: 16831287
[TBL] [Abstract][Full Text] [Related]
20. [Clinicopathologic and molecular characteristics of malignant gastrointestinal neuroectodermal tumors].
Zhao M; Zhao TW; Ma J; Wu CY; Chen L; Ru GQ; He XL
Zhonghua Bing Li Xue Za Zhi; 2017 Nov; 46(11):750-755. PubMed ID: 29136686
[No Abstract] [Full Text] [Related]
[Next] [New Search]
